What You Should Know:
- Quantiphi, an AI-first digital engineering company, announced a strategic minority investment in Transcell, a pioneering stem cell-based biotech innovator. This collaboration marks a significant step forward in the integration of AI and biotechnology for drug discovery and development.
- By combining Quantiphi’s AI expertise with Transcell’s stem cell technology, the partnership aims to accelerate the development of innovative treatments while reducing
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
PathAI Introduces AI-Based Measurement for MASH Scoring
What You Should Know:
- PathAI, a leader in AI-powered digital pathology solutions, announced today the launch of AIM-MASH on its AISight Image Management System (IMS).
- The new product offers advanced AI-based measurement tools to support pathologists in assessing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) using the MASH Clinical Research Network (CRN) Activity Score.
AIM-MASH Integration with AISight
By integrating AIM-MASH with AISight, PathAI
Read More
Citeline Launches AI-Powered Tools for Clinical Trials
What You Should Know:
- Citeline, a provider of intelligence solutions for the life sciences industry, today announced the launch of Protocol SmartDesign and Investigator SmartSelect, two new AI-powered tools designed to streamline and optimize clinical trial development.
- These innovative solutions are part of the Citeline SmartSolutions suite, which leverages the company's extensive data assets to deliver actionable insights for life sciences organizations.
How Protocol
Read More
Absci and MSK Collaborate on Generative AI Drug Discovery
What You Should Know:
- Absci Corporation, a leader in generative AI drug creation, today announced a strategic collaboration with Memorial Sloan Kettering Cancer Center (MSK) to develop up to six novel cancer therapeutics.
- By combining Absci’s AI platform with MSK’s renowned cancer research expertise, the partnership aims to accelerate the discovery and development of new treatments for this devastating disease.
Absci's Integrated Drug Creation Platform
Absci's Integrated
Read More
SVB Report: 2024 Mid-Year Healthcare Investments and Exits
What You Should Know:
- The healthcare venture capital landscape experienced a resurgence in the first half of 2024, according to a new report from Silicon Valley Bank (SVB). Despite ongoing economic challenges, 89% of US VC funds exceeding $25M successfully met their fundraising targets.
- The report, "2024 Mid-Year Healthcare Investments and Exits," delves into venture capital activity across the healthcare sector, including biopharma, healthtech, medical device, and
Read More
Trialbee & Belong.Life Partner to Increase Clinical Trial Awareness and Enrollment
What You Should Know:
- Trialbee, the global leader in technology-driven patient recruitment for clinical trials, is launching an Omnichannel Network partnership with Belong.Life, a leading global provider of disease-specific AI-powered patient education and support solutions, to identify and connect qualified patients with clinical research.
- Through this partnership, Trialbee and Belong.Life will streamline the recruitment process and introduce clinical research to millions of
Read More
Pangea Biomed Partners with Hadassah to Develop Cancer Treatment
What You Should Know:
- Pangea Biomed, the startup behind the world’s most advanced cancer response predictor, ENLIGHT, is announcing a strategic collaboration with the Sharett Institute of Oncology and Hadassah Cancer Research Institute (HCRI) at the Hadassah University Hospital Ein-Kerem and Ultima Genomics, the developer of a revolutionary architecture for high-throughput genomic sequencing.
- This partnership aims to enhance the accuracy and effectiveness of solid tumor cancer
Read More
Physicians Reveals GLP-1s for Weight Loss are Overprescribed and Unsustainable
What You Should Know:
- A large majority of physicians feel GLP-1s are being overprescribed, according to a new survey from Virta Health, a leader in type 2 diabetes reversal.
- The Virta Health survey was conducted in partnership with Beresford Research and included 300 primary care providers, endocrinologists, and obesity specialists across the United States sheds light on the medical community's views on the rapidly growing class of GLP-1 medications, often hailed as
Read More
Seqera Acquires Tinybio to Democratize Access to AI-Powered Bioinformatics
What You Should Know:
- Seqera, a provider of scientific data analysis for life sciences and creator of Nextflow, announced the acquisition of Tinybio, a rising tech-bio startup specializing in AI-powered bioinformatics tools.
- The acquisition reinforces Seqera's commitment to building a robust online platform that empowers scientists with cutting-edge resources. Financial details of the acquisition were not disclosed.
Bridging the Gap Between Scientists and
Read More
venBio Raises $528M for Fifth Life Sciences Fund
What You Should Know:
- venBio, a leading life sciences venture capital firm, announced the successful closing of its fifth fund, venBio Fund V, with over $528M in capital commitments.
- The new fund will focus on investing in biopharmaceutical companies developing innovative treatments for unmet medical needs.
venBio Fund V Focus
With a strong track record of successful investments in companies such as Labrys Biologics, Aragon Pharmaceuticals, and Seragon
Read More
